9 Oct 2026 03:00
The Black Market for Investigational GLP-1 Drugs
JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain." Related Content:
